Title |
Neonatal treatment of CINCA syndrome
|
---|---|
Published in |
Pediatric Rheumatology, December 2014
|
DOI | 10.1186/1546-0096-12-52 |
Pubmed ID | |
Authors |
Yan Paccaud, Gerald Berthet, Annette Von Scheven-Gête, Bernard Vaudaux, Yvan Mivelaz, Michael Hofer, Matthias Roth-Kleiner |
Abstract |
Chronic Infantile Neurological Cutaneous Articular (CINCA) syndrome, also called Neonatal Onset Multisystem Inflammatory Disease (NOMID) is a chronic disease with early onset affecting mainly the central nervous system, bones and joints and may lead to permanent damage. We report two preterm infants with severe CINCA syndrome treated by anti-interleukin-1 in the neonatal period, although, so far, no experience with this treatment in infants younger than three months of age has been reported. A review of the literature was performed with focus on treatment and neonatal features of CINCA syndrome. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 25 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 4 | 16% |
Researcher | 3 | 12% |
Student > Postgraduate | 3 | 12% |
Student > Doctoral Student | 2 | 8% |
Student > Bachelor | 1 | 4% |
Other | 6 | 24% |
Unknown | 6 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 40% |
Biochemistry, Genetics and Molecular Biology | 2 | 8% |
Psychology | 2 | 8% |
Nursing and Health Professions | 1 | 4% |
Unspecified | 1 | 4% |
Other | 2 | 8% |
Unknown | 7 | 28% |